29 April 2024
29 April 2024 Truqap plus Faslodex recommended for approval in the EU by CHMP for patients with advanced ER-positive breast cancer Recommendation based on CAPItello-291 results which…
29 April 2024 Enhertu demonstrated statistically significant and clinically meaningful improvement in progression-free survival in HR-positive, HER2-low metastatic breast cancer following one or more lines…
26 April 2024
Further to the announcement by Anglo American plc (“Anglo American”) on 24 April, the Board of Anglo American (the “Board”) provides an update regarding…
RECOMMENDED CASH ACQUISITION of Darktrace plc by Luke Bidco Limited (a newly-formed company indirectly wholly-owned by funds managed and/or advised by Thoma Bravo, L.P.)…
25 April 2024
The Board of Anglo American notes the recent press speculation and confirms that it is has received an unsolicited, non-binding and highly conditional combination…
Q1 Trading Statement Persimmon Plc is today providing an update on trading for the period from 1 January 2024 to 31 March 2024, ahead of its…
Q1 2024 highlights (All growth rates on an organic constant currency basis unless otherwise stated) â— Solid growth: Total income (excl. recoveries) +7.3% incl. M&A,…
Unilever Trading Statement – First Quarter 2024 Improved volume growth led by Power Brands First Quarter 2024 (unaudited) USG Turnover vs 2023 Unilever…